Levetiracetam in stiff-person syndrome
Levetiracetam in stiff-person syndrome
About this item
Full title
Author / Creator
Publisher
Dordrecht: D. Steinkopff-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
Dordrecht: D. Steinkopff-Verlag
Subjects
More information
Scope and Contents
Contents
We studied the effects of oral levetiracetam (LEV) (500 mg twice daily) in three women with stiff-person syndrome in a single-blind, placebo-controlled study. The severity of muscle rigidity and of paroxysmal symptoms was assessed by EMG and clinically by a rating scale of 0–4 and by the Patients Global Impressions Scale. LEV was well tolerated. On...
Alternative Titles
Full title
Levetiracetam in stiff-person syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_66655328
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_66655328
Other Identifiers
ISSN
0340-5354
E-ISSN
1432-1459
DOI
10.1007/s00415-008-0007-7
